Landon J. Inge

alpha-Catenin overrides Src-dependent activation of beta-catenin oncogenic signaling.

Expression of LKB1 tumor suppressor in non-small cell lung cancer determines sensitivity to 2-deoxyglucose.

Genomic characterization of the inflammatory response initiated by surgical intervention and the effect of perioperative cyclooxygenase 2 blockade.

Na,K-ATPase subunits as markers for epithelial-mesenchymal transition in cancer and fibrosis.

Immunosuppression-induced bronchial epithelial-mesenchymal transition: a potential contributor to obliterative bronchiolitis.

Soluble E-cadherin promotes cell survival by activating epidermal growth factor receptor.

Na,K-ATPase β-subunit cis homo-oligomerization is necessary for epithelial lumen formation in mammalian cells.

Dasatinib, a small molecule inhibitor of the Src kinase, reduces the growth and activates apoptosis in pre-neoplastic Barrett's esophagus cell lines: evidence for a noninvasive treatment of high-grade dysplasia.

Gramicidin A blocks tumor growth and angiogenesis through inhibition of hypoxia-inducible factor in renal cell carcinoma.

FN14 expression correlates with MET in NSCLC and promotes MET-driven cell invasion.

LKB1 inactivation sensitizes non-small cell lung cancer to pharmacological aggravation of ER stress.